Recent retrospective cohort data and a prospective randomized sham controlled trial have
clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett's …

This issue of Gastrointestinal Endoscopy contains a single center randomized trial of
endoscopic ablation therapy vs. surveillance in patients with Barrett's esophagus. 1 Ackroyd …

BACKGROUND: For patients with Barrett's esophagus (BE), life-long surveillance
endoscopy is recommended because of an elevated risk for developing dysplasia and …

Background and study aims: It has been postulated that the endoscopic ablation of Barrett's
esophagus can lead to complete eradication of the disease. This study was undertaken to …

Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal
adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States …

The excellent efficacy, side-effect profile, and cost-effectiveness appear to make RFA the
intervention of choice in cases of high-grade dysplasia. RFA for low-grade dysplasia may be …

Since Barrett's esophagus is a precancerous condition, efforts have been made for its
eradication by various ablative techniques. Initially, laser ablation was attempted in non …

The management of Barrett esophagus is evolving with the emergence of new endoscopic
technologies. Traditionally, patients with high-grade dysplasia or cancer were referred for …

In the last 5–10 years, endoscopic ablative therapies have been gaining ground as
treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer …

Besides esophagectomy and antireflux therapy with intensive endoscopic surveillance,
endoscopic ablation therapy is a new treatment modality for Barrett's esophagus (BE) with …